Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study

INTRODUCTION: To assess the effect of exenatide and pioglitazone or basal-bolus insulin on diabetic peripheral neuropathy (DPN) in patients with poorly controlled type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This is a substudy of the Qatar Study, an open-label, randomized controlled trial. 38...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponirakis, Georgios, Abdul-Ghani, Muhammad A, Jayyousi, Amin, Almuhannadi, Hamad, Petropoulos, Ioannis N, Khan, Adnan, Gad, Hoda, Migahid, Osama, Megahed, Ayman, DeFronzo, Ralph, Mahfoud, Ziyad, Hassan, Mona, Al Hamad, Hanadi, Ramadan, Marwan, Alam, Uazman, Malik, Rayaz A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312325/
https://www.ncbi.nlm.nih.gov/pubmed/32576561
http://dx.doi.org/10.1136/bmjdrc-2020-001420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312325/
https://www.ncbi.nlm.nih.gov/pubmed/32576561
http://dx.doi.org/10.1136/bmjdrc-2020-001420

Ejemplares similares